Zen Shape

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

inositol, Quantity: 16.11 mg; potassium iodide, Quantity: 176.59 microgram (Equivalent: iodine, Qty 135 microgram); Camellia sinensis, Quantity: 52.63 mg (Equivalent: Camellia sinensis, Qty 1.315 g; Equivalent: caffeine, Qty 5.26 mg); choline bitartrate, Quantity: 62.81 mg; chromium picolinate, Quantity: 200 microgram (Equivalent: chromium, Qty 25 microgram); chromic chloride hexahydrate, Quantity: 128.14 microgram (Equivalent: chromium, Qty 25 microgram); Coffea canephora, Quantity: 100 mg (Equivalent: caffeine, Qty 2 mg; Equivalent: chlorogenic acids (of Coffea canephora), Qty 47.5 mg; Equivalent: 5-caffeoylquinic acid (of Coffea canephora), Qty 12.5 mg; Equivalent: Coffea canephora, Qty 700 mg)

Available from:

Jeunesse Global Australia Pty Ltd

INN (International Name):

chromic chloride hexahydrate,Camellia sinensis,Choline bitartrate,Chromium picolinate,Coffea canephora,Inositol,Potassium iodide

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; crospovidone; hypromellose; povidone; croscarmellose sodium; Carnauba Wax; magnesium stearate; macrogol 400; maltodextrin; silicon dioxide

Administration route:

Oral

Therapeutic indications:

Maintain/support body metabolism/metabolic rate ; Maintain/support energy production ; Maintain/support heat/energy production/thermogenesis ; Maintain/support general health and wellbeing ; Maintain/support healthy thyroid gland function ; Maintain/support healthy thyroid hormones ; Maintain/support thyroid gland health ; Aid/assist thyroid hormone production ; Aid/assist/helps glucose/sugar/carbohydrate metabolism ; Helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; Aid/assist/helps metabolism of (state vitamin/mineral/nutrient)

Product summary:

Visual Identification: ;

Authorization status:

Licence status A

Authorization date:

2017-03-22